Publications/White Papers


Innovative Access Agreements: A potential payer solution for Cell & Gene Therapies

A US and EU perspective

By Daniele Severi Bruni & Sophie Schmitz

What’s the idea?

Payer concerns over increasing cost of therapies and uncertainty of clinical data has led to a growing interest in market access tools. Experts Daniele Severi Bruni partner at MKO and Sophie Schmitz from Partners4Access discuss this potential payer solution for Cell & Gene Therapies.

Download the full article here

All Rights Reserved ©   Privacy   Partners 4 Access 2018